FDA Approves RAMELTEON — Micro Labs Limited

# FDA Approves Generic Ramelteon by Micro Labs Limited The FDA has approved Micro Labs Limited's generic version of Ramelteon (ANDA215243), an oral melatonin receptor agonist used to treat insomnia, marking another competitive entry in the sleep disorder medication market. The approval is expected to increase price competition and expand patient access to this established treatment option.